Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;174(6):W54-W55.
doi: 10.7326/L21-0223. Epub 2021 Apr 27.

Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Katherine Mackey  1 , Devan Kansagara  1 , Kathryn Vela  1
Affiliations

Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Katherine Mackey et al. Ann Intern Med. 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L21-0223.

Update of

References

    1. Mackey K , Kansagara D , Vela K . Update alert 7: risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults [Letter]. Ann Intern Med. 2021;174:W25-W29. [PMID: ]. doi: 10.7326/L20-1446 - DOI - PMC - PubMed
    1. Mackey K , King VJ , Gurley S , et al. Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: a living systematic review. Ann Intern Med. 2020;173:195-203. [PMID: ]. doi: 10.7326/M20-1515 - DOI - PMC - PubMed
    1. Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 [clinical trial]. Accessed at www.clinicaltrials.gov/ct2/show/NCT04338009 on 8 April 2021.
    1. Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 (BRACE-CORONA) [clinical trial]. Accessed at www.clinicaltrials.gov/ct2/show/NCT04364893 on 8 April 2021.
    1. Coronavirus (COVID-19) ACEi/ARB Investigation (CORONACION) [clinical trial]. Accessed at www.clinicaltrials.gov/ct2/show/NCT04330300 on 8 April 2021.